Literature DB >> 17114062

From anatomical to biological target volumes: the role of PET in radiation treatment planning.

D A X Schinagl1, J H A M Kaanders, W J G Oyen.   

Abstract

Progress in radiation oncology requires a re-evaluation of the methods of target volume delineation beyond anatomical localization. New molecular imaging techniques for tumour visualisation such as positron emission tomography (PET) provide insight into tumour characteristics and can be complementary to the anatomical data of computed tomography or magnetic resonance imaging. In this review, three issues are discussed: First, can PET identify a tumour more accurately? Second, can biological tumour characteristics be visualised? Third, can intratumoural heterogeneity of these characteristics be identified? (c) International Cancer Imaging Society.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114062      PMCID： PMC1805069          DOI： 10.1102/1470-7330.2006.9017

Source DB:  PubMed          Journal:  Cancer Imaging        ISSN： 1470-7330            Impact factor:   3.909


  63 in total

1.  FDG-PET in radiotherapy treatment planning: Pandora's box?

Authors:  Arnold C Paulino; Peter A S Johnstone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

2.  Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area.

Authors:  W V Vogel; D A X Schinagl; J A Van Dalen; J H A M Kaanders; W J G Oyen
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 2.346

3.  18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.

Authors:  Shu-Hang Ng; Tzu-Chen Yen; Chun-Ta Liao; Joseph Tung-Chieh Chang; Sheng-Chieh Chan; Sheung-Fat Ko; Hung-Ming Wang; Ho-Fai Wong
Journal:  J Nucl Med       Date:  2005-07       Impact factor: 10.057

4.  Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.

Authors:  J A Raleigh; D P Calkins-Adams; L H Rinker; C A Ballenger; M C Weissler; W C Fowler; D B Novotny; M A Varia
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

5.  Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.

Authors:  Roel J H M Steenbakkers; Joop C Duppen; Isabelle Fitton; Kirsten E I Deurloo; Lambert J Zijp; Emile F I Comans; Apollonia L J Uitterhoeve; Patrick T R Rodrigus; Gijsbert W P Kramer; Johan Bussink; Katrien De Jaeger; José S A Belderbos; Peter J C M Nowak; Marcel van Herk; Coen R N Rasch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-28       Impact factor: 7.038

6.  Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.

Authors:  Lutz W Kracht; Hrvoje Miletic; Susanne Busch; Andreas H Jacobs; Jurgen Voges; Moritz Hoevels; Johannes C Klein; Karl Herholz; Wolf-D Heiss
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

7.  Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.

Authors:  Irina Velikyan; Asa Liljegren Sundberg; Orjan Lindhe; A Urban Höglund; Olof Eriksson; Eva Werner; Jorgen Carlsson; Mats Bergström; Bengt Långström; Vladimir Tolmachev
Journal:  J Nucl Med       Date:  2005-11       Impact factor: 10.057

8.  (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Authors:  Lars R Perk; Gerard W M Visser; Maria J W D Vosjan; Marijke Stigter-van Walsum; Bernard M Tijink; C René Leemans; Guus A M S van Dongen
Journal:  J Nucl Med       Date:  2005-11       Impact factor: 10.057

9.  Defining a radiotherapy target with positron emission tomography.

Authors:  Quinten C Black; Inga S Grills; Larry L Kestin; Ching-Yee O Wong; John W Wong; Alvaro A Martinez; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

10.  The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.

Authors:  M W Gross; W A Weber; H J Feldmann; P Bartenstein; M Schwaiger; M Molls
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-15       Impact factor: 7.038
View more
  10 in total

1.  Use of PET/CT instead of CT-only when planning for radiation therapy does not notably increase life years lost in children being treated for cancer.

Authors:  Josefine S Kornerup; Patrik Brodin; Charlotte Birk Christensen; Thomas Björk-Eriksson; Anne Kiil-Berthelsen; Lise Borgwardt; Per Munck Af Rosenschöld
Journal:  Pediatr Radiol       Date:  2014-11-07

2.  A hardware investigation of robotic SPECT for functional and molecular imaging onboard radiation therapy systems.

Authors:  Susu Yan; James Bowsher; MengHeng Tough; Lin Cheng; Fang-Fang Yin
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

3.  PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy.

Authors:  J S Kornerup; N P Brodin; T Björk-Eriksson; C Birk Christensen; A Kiil-Berthelsen; M C Aznar; C Hollensen; E Markova; P Munck Af Rosenschöld
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

4.  Radiosynthesis of the tumor hypoxia marker [18F]TFMISO via O-[18F]trifluoroethylation reveals a striking difference between trifluoroethyl tosylate and iodide in regiochemical reactivity toward oxygen nucleophiles.

Authors:  Makiko Suehiro; Guangbin Yang; Geralda Torchon; Ellen Ackerstaff; John Humm; Jason Koutcher; Ouathek Ouerfelli
Journal:  Bioorg Med Chem       Date:  2011-02-18       Impact factor: 3.641

5.  Current concepts on imaging in radiotherapy.

Authors:  Michela Lecchi; Piero Fossati; Federica Elisei; Roberto Orecchia; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-31       Impact factor: 9.236

6.  Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer.

Authors:  Dominic A X Schinagl; Paul N Span; Frank J A van den Hoogen; Matthias A W Merkx; Piet J Slootweg; Wim J G Oyen; Johannes H A M Kaanders
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-14       Impact factor: 9.236

7.  Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?

Authors:  Makiko Suehiro; Paul Burgman; Sean Carlin; Sean Burke; Guangbin Yang; Ouathek Ouerfelli; Christoph Oehler-Janne; Joseph O'Donoghue; Clifton Ling; John Humm
Journal:  Nucl Med Biol       Date:  2009-05-07       Impact factor: 2.408

8.  Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.

Authors:  Seung Hyun Son; Do-Hoon Kim; Chae Moon Hong; Choon-Young Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  BMC Cancer       Date:  2014-08-12       Impact factor: 4.430

9.  Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast.

Authors:  Chin-Chuan Chang; Chao-Jung Chen; Wen-Ling Hsu; Shu-Min Chang; Ying-Fong Huang; Yu-Chang Tyan
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

10.  A partial volume effect correction tailored for 18F-FDG-PET oncological studies.

Authors:  F Gallivanone; C Canevari; L Gianolli; C Salvatore; P A Della Rosa; M C Gilardi; I Castiglioni
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.